EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecules and Cells

• Publication date

  2012-12-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molcel.2012.09.028PMID 23123196PMCID PMC3526114
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonmetabolic functions of pyruvate kinase isoform M2 in controlling cell cycle progression and tumorigenesis

  2012cited by this paper
• PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis.

  2012cited by this paper
• Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation

  2011cited by this paper
• Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth

  2011cited by this paper
• Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1.

  2011cited by this paper
• 選択的スプライシングレプレッサーhnRNP A1/A2とPTBはピルビン酸キナーゼアイソフォーム発現と細胞代謝に影響する

  2010cited by this paper
• The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism

  2010influential reference
• HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer

  2010influential reference
• Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

  2009cited by this paper
• Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation.

  2009cited by this paper
• EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin.

  2009cited by this paper
• The role of ubiquitin in NF-kappaB regulatory pathways.

  2009influential reference
• Involvement of linear polyubiquitylation of NEMO in NF-κB activation

  2009cited by this paper
• The Zinc Finger of NEMO Is a Functional Ubiquitin-binding Domain*

  2009cited by this paper
• New regulators of NF-κB in inflammation

  2008cited by this paper
• NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α

  2008cited by this paper
• The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

  2008cited by this paper
• NF-κB in carcinoma therapy and prevention

  2008influential reference
• NF-kappaB in carcinoma therapy and prevention.

  2008influential reference
• On/Off-regulation of phospholipase C-γ1-mediated signal transduction

  2007cited by this paper
• Protein kinase C family: On the crossroads of cell signaling in skin and tumor epithelium

  2007cited by this paper
• Malignant astrocytic glioma: genetics, biology, and paths to treatment.

  2007cited by this paper
• Amplitude Control of Protein Kinase C by RINCK, a Novel E3 Ubiquitin Ligase*

  2007cited by this paper
• On/off-regulation of phospholipase C-gamma 1-mediated signal transduction.

  2007cited by this paper
• Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].

  2006cited by this paper
• Transcriptional regulation via the NF-kappaB signaling module.

  2006cited by this paper
• Nuclear factor-κB in cancer development and progression

  2006cited by this paper
• Transcriptional regulation via the NF-κB signaling module

  2006cited by this paper
• Polypyrimidine tract binding protein and Notch1 are independently re-expressed in glioma

  2006cited by this paper
• Nuclear factor-kappaB in cancer development and progression.

  2006cited by this paper
• Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO.

  2006cited by this paper
• Mutual regulation of conventional protein kinase C and a ubiquitin ligase complex.

  2006cited by this paper
• Pyruvate kinase type M2 and its role in tumor growth and spreading.

  2005cited by this paper
• Signaling to NF-kappaB.

  2004cited by this paper
• Requirement of autophosphorylated tyrosine 992 of EGF receptor and its docking protein phospholipase Cγ1 for membrane ruffle formation

  2003cited by this paper
• EGF mutant receptor vIII as a molecular target in cancer therapy.

  2001cited by this paper
• TAK1 is a ubiquitin-dependent kinase of MKK and IKK

  2001cited by this paper
• Antagonistic Effects of Protein Kinase C α and δ on Both Transformation and Phospholipase D Activity Mediated by the Epidermal Growth Factor Receptor

  1999cited by this paper
• Antagonistic effects of protein kinase C alpha and delta on both transformation and phospholipase D activity mediated by the epidermal growth factor receptor.

  1999cited by this paper
• Activation of Protein Kinase C Triggers Its Ubiquitination and Degradation

  1998influential reference
• Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

  1998cited by this paper
• Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials.

  1997cited by this paper
• An examination of conditions for the cleavage of polypeptide chains with cyanogen bromide: application to catalase.

  1969cited by this paper

• Role of elevation of glycolysis in tumor-associated macrophages in glioblastoma immune evasion and therapeutic implications

  2026cites this paper
• Redundancy in Growth Factor Receptor Signaling in Adult Astrocytoma Resistance to Small-Molecule Tyrosine Kinase Inhibitors

  2026cites this paper
• Emerging multi-omics biomarkers in glioblastoma: Integrative insights from genomics to metabolomics.

  2026cites this paper
• Nucleus-translocated glucokinase functions as a protein kinase to phosphorylate TAZ and promote tumour growth

  2025cites this paper
• Moonlighting functions of glucose metabolic enzymes and metabolites in cancer

  2025cites this paper
• Metabolic reprogramming on breast cancer stem Cells: Proliferation and self-renewal, epithelial-mesenchymal transition (EMT), and drug resistance.

  2025cites this paper
• Glioblastoma at the crossroads: current understanding and future therapeutic horizons

  2025cites this paper
• A comprehensive characterization of metabolic signatures—hypoxia, glycolysis, and lactylation—in non-healing diabetic foot ulcers

  2025cites this paper
• “Friends or foes”: a new perspective of tumour metabolic transcriptional modification

  2025cites this paper
• The Emerging Roles of Metabolic Reprogramming in Non-Small Cell Lung Cancer Progression.

  2025cites this paper
• Ubiquitination in cancer: mechanisms and therapeutic opportunities

  2025cites this paper
• The Pivotal Role of NF-κB in Glioblastoma: Mechanisms of Activation and Therapeutic Implications

  2025cites this paper
• The role of lncRNAs in the interplay of signaling pathways and epigenetic mechanisms in glioma.

  2025cites this paper
• Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies

  2025cites this paper
• Flavonoids in Brain Ischemia-Reperfusion and their Effect on Kinases as Signaling Pathway Activity.

  2025cites this paper
• MicroRNA-122 regulates inflammatory and autophagic proteins by downregulating pyruvate kinase M2 in non-alcoholic fatty liver disease

  2024cites this paper
• p53 induces circFRMD4A to suppress cancer development through glycolytic reprogramming and cuproptosis.

  2024cites this paper
• Dux activates metabolism-lactylation-MET network during early iPSC reprogramming with Brg1 as the histone lactylation reader

  2024cites this paper
• N6‐isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by targeting PKM2 expression and activity

  2024cites this paper
• Practical immunomodulatory landscape of glioblastoma multiforme (GBM) therapy

  2024cites this paper
• Exosomal long non-coding RNA-LINC00839 promotes lung adenocarcinoma progression by activating NF-κB signaling pathway

  2024cites this paper
• Emerging Therapies for Glioblastoma

  2024cites this paper
• Delta‐Like Homolog 2 Facilitates Malignancy of Hepatocellular Carcinoma via Activating EGFR/PKM2 Signaling Pathway

  2024cites this paper
• The Regulatory Network of hnRNPs Underlying Regulating PKM Alternative Splicing in Tumor Progression

  2024cites this paper
• Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets

  2024cites this paper
• Exploring the diverse role of pyruvate kinase M2 in cancer: Navigating beyond glycolysis and the Warburg effect.

  2024cites this paper
• Shikonin inhibits the growth of anaplastic thyroid carcinoma cells by promoting ferroptosis and inhibiting glycolysis

  2024cites this paper
• Hexosaminidase B-driven cancer cell-macrophage co-dependency promotes glycolysis addiction and tumorigenesis in glioblastoma

  2024cites this paper
• MicroRNA-146 family: Molecular insights into their role in regulation of signaling pathways in glioma progression.

  2024cites this paper
• Suppressing nuclear translocation of microglial PKM2 confers neuroprotection via downregulation of neuroinflammation after mouse cerebral ischemia-reperfusion injury.

  2024cites this paper
• The multifaceted modulation of mitochondrial metabolism in tumorigenesis.

  2024cites this paper
• KITENIN promotes aerobic glycolysis through PKM2 induction by upregulating the c-Myc/hnRNPs axis in colorectal cancer

  2023cites this paper
• Recent advances in understanding brain cancer metabolomics: a review

  2023cites this paper
• MiR-297 inhibits tumour progression of liver cancer by targeting PTBP3

  2023cites this paper
• Human papillomavirus 16 E6 promotes angiogenesis of lung cancer via SNHG1

  2023cites this paper
• MiR-218-5p/EGFR Signaling in Arsenic-Induced Carcinogenesis

  2023cites this paper
• PKM2 controls the translation of TFE3 to maintain the integrity of the Golgi apparatus for the survival of HeLa and ME‐180 cervical cancer cells

  2023cites this paper
• Molecular Analysis of the Superior Efficacy of a Dual Epidermal Growth Factor Receptor (EGFR)-DNA-Targeting Combi-Molecule in Comparison with Its Putative Prodrugs 6-Mono-Alkylamino- and 6,6-Dialkylaminoquinazoline in a Human Osteosarcoma Xenograft Model

  2023cites this paper
• The Role of PKM2 in Multiple Signaling Pathways Related to Neurological Diseases

  2023influential citation
• Metabolic Enzymes in Viral Infection and Host Innate Immunity

  2023cites this paper
• Glycolytic enzyme HK2 promotes PD-L1 expression and breast cancer cell immune evasion

  2023cites this paper
• Co-occurrence of glioma and multiple sclerosis: Prevailing theories and emerging therapies.

  2023cites this paper
• The Warburg effect on radioresistance: Survival beyond growth.

  2023cites this paper
• Functional importance of glucose transporters and chromatin epigenetic factors in Glioblastoma Multiforme (GBM): possible therapeutics

  2023cites this paper
• Research progress on the regulation and mechanism of borneol on the blood-brain barrier in pathological states: a narrative review focused on ischemic stroke and cerebral glioma

  2023cites this paper
• The roles of glycolysis in osteosarcoma

  2022cites this paper
• Single-Cell FISH Analysis Reveals Distinct Shifts in PKM Isoform Populations during Drug Resistance Acquisition

  2022cites this paper
• Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα.

  2022cites this paper
• Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review)

  2022cites this paper
• Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis

  2022cites this paper
• EGF/EGFR Promotes Salivary Adenoid Cystic Carcinoma Cell Malignant Neural Invasion via Activation of PI3K/AKT and MEK/ERK Signaling.

  2022cites this paper
• Functions and modulation of PKM2 activity by human papillomavirus E7 oncoprotein (Review)

  2022cites this paper
• Regulation of cells of the arterial wall by hypoxia and its role in the development of atherosclerosis.

  2022cites this paper
• Bile acids attenuate PKM2 pathway activation in proinflammatory microglia

  2022cites this paper
• Regulation of gene expression by glycolytic and gluconeogenic enzymes.

  2022cites this paper
• Protein kinase C epsilon promotes de novo lipogenesis and tumor growth in prostate cancer cells by regulating the phosphorylation and nuclear translocation of pyruvate kinase isoform M2.

  2022cites this paper
• Metabolic Adaptation-Mediated Cancer Survival and Progression in Oxidative Stress

  2022cites this paper
• Potential targets and treatments affect oxidative stress in gliomas: An overview of molecular mechanisms

  2022cites this paper
• Role of EGF Receptor Regulatory Networks in the Host Response to Viral Infections

  2022cites this paper
• An ErbB Lineage Co-Regulon Harbors Potentially Co-Druggable Targets for Multimodal Precision Therapy in Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9

  2022cites this paper
• Human scattered tubular cells represent a heterogeneous population of glycolytic dedifferentiated proximal tubule cells

  2022cites this paper
• SIRT6 Widely Regulates Aging, Immunity, and Cancer

  2022cites this paper
• Pyruvate kinase M2 in chronic inflammations: a potpourri of crucial protein–protein interactions

  2021cites this paper
• HIF1α/HIF2α–Sox2/Klf4 promotes the malignant progression of glioblastoma via the EGFR–PI3K/AKT signalling pathway with positive feedback under hypoxia

  2021cites this paper
• Non-Metabolic Functions of PKM2 Contribute to Cervical Cancer Cell Proliferation Induced by the HPV16 E7 Oncoprotein

  2021cites this paper
• Bidirectional Crosstalk Between Hypoxia Inducible Factors and Glucocorticoid Signalling in Health and Disease

  2021cites this paper
• The Evolving Landscape of Noncanonical Functions of Metabolic Enzymes in Cancer and Other Pathologies.

  2021cites this paper
• A short review on cross-link between pyruvate kinase (PKM2) and Glioblastoma Multiforme

  2021cites this paper
• Metabolic Alteration in Hepatocellular Carcinoma: Mechanism of Lipid Accumulation in Well-Differentiated Hepatocellular Carcinoma

  2021cites this paper
• MCM8 is regulated by EGFR signaling and promotes the growth of glioma stem cells through its interaction with DNA-replication-initiating factors

  2021cites this paper
• Connections between metabolism and epigenetic modifications in cancer

  2021cites this paper
• Linear Ubiquitination Mediates EGFR-Induced NF-κB Pathway and Tumor Development

  2021cites this paper
• Endoplasmic reticulum stress promotes sorafenib resistance via miR-188-5p/hnRNPA2B1-mediated upregulation of PKM2 in hepatocellular carcinoma

  2021cites this paper
• Transcription factors in glioblastoma - Molecular pathogenesis and clinical implications.

  2021cites this paper
• Natural Small Molecules Targeting NF-κB Signaling in Glioblastoma

  2021cites this paper
• TRIM47 activates NF-κB signaling via PKC-ε/PKD3 stabilization and contributes to endocrine therapy resistance in breast cancer

  2021cites this paper
• Multiple functions of pyruvate kinase M2 in various cell types

  2021cites this paper
• Pyruvate kinase M2 mediates fibroblast proliferation to promote tubular epithelial cell survival in acute kidney injury

  2021cites this paper
• Ketamine ameliorates depressive-like behaviors in mice through increasing glucose uptake regulated by the ERK/GLUT3 signaling pathway

  2021cites this paper
• Deubiquitinase OTUB2 exacerbates the progression of colorectal cancer by promoting PKM2 activity and glycolysis

  2021cites this paper
• A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes

  2020cites this paper
• Epigenetics of Glioblastoma Multiforme: From Molecular Mechanisms to Therapeutic Approaches.

  2020cites this paper
• Mechanisms of imipridones in targeting mitochondrial metabolism in cancer cells.

  2020cites this paper
• Is nuclear sirtuin SIRT6 a master regulator of immune function?

  2020cites this paper
• MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR‐induced NF‐κB activation

  2020cites this paper
• Phosphoribosyl Pyrophosphate Amidotransferase Promotes the Progression of Thyroid Cancer via Regulating Pyruvate Kinase M2

  2020cites this paper
• Mechanisms of protein kinase C epsilon down-regulation by transforming growth factor-beta in lung cancer cells

  2020cites this paper
• Protein kinase function of pyruvate kinase M2 and cancer

  2020cites this paper
• EGF promotes DKK1 transcription in hepatocellular carcinoma by enhancing the phosphorylation and acetylation of histone H3

  2020cites this paper
• Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis

  2020cites this paper
• APC loss induces Warburg effect via increased PKM2 transcription in colorectal cancer

  2020cites this paper
• Cancer cell metabolism: rewiring the mitochondrial hub.

  2020cites this paper
• HIF-1β Positively Regulates NF-κB Activity via Direct Control of TRAF6

  2020cites this paper
• Phosphoribosyl Pyrophosphate Amidotransferase Promotes the Progression of Thyroid Cancer via Regulating Pyruvate Kinase M2

  2020cites this paper
• β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion

  2020cites this paper
• Emerging Roles and Therapeutic Interventions of Aerobic Glycolysis in Glioma

  2020cites this paper
• – a BrieF OvervieW

  2020cites this paper
• NF-kappa B interacting long noncoding RNA enhances the Warburg effect and angiogenesis and is associated with decreased survival of patients with gliomas

  2020cites this paper
• PHGDH as a mechanism for resistance in metabolically-driven cancers

  2020cites this paper